Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.51USD
18 Jan 2019
Change (% chg)

$0.03 (+1.21%)
Prev Close
$2.48
Open
$2.58
Day's High
$2.64
Day's Low
$2.43
Volume
319,960
Avg. Vol
628,415
52-wk High
$5.05
52-wk Low
$1.65

Select another date:

Fri, Nov 2 2018

Photo

FDA approves AcelRx Pharma's opioid pain drug

The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.

UPDATE 2-U.S. FDA approves AcelRx Pharma's opioid pain drug

Nov 2 The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.

AcelRx Pharma's opioid pain drug gets U.S. FDA nod

Nov 2 The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based pain treatment, a fast-acting pill.

AcelRx shares surge after FDA staff says opioid safe

AcelRx Pharmaceuticals Inc's shares surged 30 percent on Wednesday after U.S. Food and Administration staff said the company's opioid treatment was safe and effective, bringing it one step closer to a marketing approval.

UPDATE 2-AcelRx shares surge after FDA staff says opioid safe

Oct 10 AcelRx Pharmaceuticals Inc's shares surged 30 percent on Wednesday after U.S. Food and Administration staff said the company's opioid treatment was safe and effective, bringing it one step closer to a marketing approval.

Select another date: